Trump announces deal on weight loss drug prices
Digest more
Tenaya Therapeutics said on Friday the U. Food and Drug Administration has placed a clinical hold on its trial of an experimental gene therapy for a type of rare inherited heart disease.
Senate Democrats warned the Trump administration against imposing additional restrictions on access to abortion pills in light of the Food and Drug Administration’s (FDA) “own review of the
FDA's digital advisors could nudge the agency to clarify how its rules apply to medical applications of generative AI, including therapy chatbots.
Here’s what you need to know about the “mystery liquids” being sold to cost-cutters and unqualified injectors.
An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the latest scandal at the Food and Drug Administration, an agency that industry outsiders are calling a “clown show” and “soap opera” amid the Trump administration’s leadership, according to reporting by Stat News.
George Tidmarsh left the agency amid accusations of misusing his authority and after clashing with another top official.
4don MSN
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct
The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct. A federal spokesperson said Dr.
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave Friday, an HHS spokeswoman said.
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one day before he was named in a federal defamation lawsuit filed in Maryland by Aurinia Pharmaceuticals Inc.